|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1992-5-28
|
|
pubmed:abstractText |
Allogeneic bone marrow transplantation (BMT) is an option for some patients with chronic myelogenous leukemia (CML). We retrospectively evaluated the effect of various risk factors observed at diagnosis and at transplantation on survival, event-free survival (EFS), and relapse after BMT.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
779-89
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:1569450-Adolescent,
pubmed-meshheading:1569450-Adult,
pubmed-meshheading:1569450-Analysis of Variance,
pubmed-meshheading:1569450-Bone Marrow Transplantation,
pubmed-meshheading:1569450-Child,
pubmed-meshheading:1569450-Child, Preschool,
pubmed-meshheading:1569450-Combined Modality Therapy,
pubmed-meshheading:1569450-Cyclophosphamide,
pubmed-meshheading:1569450-Cyclosporine,
pubmed-meshheading:1569450-Female,
pubmed-meshheading:1569450-Graft vs Host Disease,
pubmed-meshheading:1569450-Humans,
pubmed-meshheading:1569450-Leukemia, Myeloid, Chronic-Phase,
pubmed-meshheading:1569450-Male,
pubmed-meshheading:1569450-Middle Aged,
pubmed-meshheading:1569450-Prognosis,
pubmed-meshheading:1569450-Retrospective Studies,
pubmed-meshheading:1569450-Risk Factors,
pubmed-meshheading:1569450-Survival Analysis,
pubmed-meshheading:1569450-Whole-Body Irradiation
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits.
|
|
pubmed:affiliation |
Bone Marrow Transplantation Unit, Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, MD.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
